Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

Data Sources

Data sources we collected to analyse this study.

Full Text
PDF
Crossref
PubMed
Classification
Summary
Quality Score
Content

Publication

Journal

The New England journal of medicine

Year

2023

Authors

Ania M Jastreboff, L. Kaplan, J. Frias, Qiwei Wu, Yu Du, S. Gurbuz, T. Coskun, A. Haupt, Z. Milicevic, M. Hartman

582 citations
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. — Quality Score & Summary | Fit Body Science